MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
5.29
+0.41
+8.40%
After Hours: 5.25 -0.04 -0.76% 19:59 02/23 EST
OPEN
5.06
PREV CLOSE
4.880
HIGH
5.46
LOW
4.910
VOLUME
18.65M
TURNOVER
0
52 WEEK HIGH
11.36
52 WEEK LOW
3.532
MARKET CAP
628.40M
P/E (TTM)
-0.8297
1D
5D
1M
3M
1Y
5Y
Earnings week ahead: Salesforce, Plug Power, Zoom, Snowflake, AMC Entertainment and more
Earnings News Earnings week ahead: Salesforce, Plug Power, Zoom, Snowflake, AMC Entertainment and more. The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce and other companies. The entertainment industry will also be in the spotlight with AMC Entertainment Holdings and Paramount Global scheduled to report.
Seeking Alpha · 16h ago
Novavax Q4 Earnings Preview: Settlement With Gavi Doesn't Solve Problems
Seeking Alpha · 2d ago
Notable Thursday Option Activity: FCFS, SNOW, NVAX
NASDAQ · 3d ago
Novavax (NASDAQ:NVAX) Settles, Shares Blast Up
TipRanks · 3d ago
Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.
Novavax reached a settlement with nongovernmental organization Gavi for its Covid-19 vaccine. Strong earnings from Moderna also were helping to push the stock higher. Novavax shares are surging 25% Thursday. Moderna posted fourth-quarter earnings and revenue above Wall Street estimates.
Barron‘s · 3d ago
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. Fell 7.5% to $71.34 on Thursday. The company reported mixed fourth-quarter financial results. La Rosa Holdings Corp. Shares jumped 160.7% after the company announced the sale of a stake in BuzzFeed. Novavax, Inc., and Root were among the other stocks moving in the mid-day session.
Benzinga · 3d ago
Optimizing for Growth: Novavax’s Settlement, Cost Reductions, and CIC Vaccine Propel Buy Rating
TipRanks · 3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Monopar Therapeutics shares increased by 85.9% to $1.06 during Thursday's regular session. Ocular Therapeutix stock rose 30.11%. Novavax shares rose 24.62%. Q4 earnings report came out yesterday. Losers Synaptogenix (NASDAQ:SNPX) and BioSig Technologies.
Benzinga · 3d ago
More
About NVAX
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company has developed and begun commercialization of its lead product, NVX-CoV2373, which is a COVID-19 vaccine. NVX-CoV2373 has received approval, interim authorization, provisional approval, conditional marketing authorization (CMA), and emergency use authorization (EUA) from multiple regulatory authorities globally for both adult and adolescent populations as a primary series and for both homologous and heterologous booster indications in over 40 countries. It is also developing an influenza vaccine candidate, quadrivalent nanoparticle influenza vaccine (qNIV); a COVID-19-Influenza Combination (CIC) vaccine candidate; and additional vaccine candidates, including a COVID-19 variant strain-containing monovalent or bivalent formulation. In addition, its other areas of focus include respiratory syncytial virus (RSV) and malaria.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.